Cancer Genomics and Epigenomics

Epigenetics is defined as heritable changes in gene activity that occurs without alterations in the DNA sequence. The “Cancer Genomics and Epigenomes” have been widely investigated for their involvement in cancer to understand the basic processes of different malignancies. The aggregation of genetic and epigenetic alteration also displays a wide range of heterogeneity making it necessary to develop personalized treatment strategies.

  • Genome plasticity
  • Genetics and genomics
  • Epigenetics
  • Chromatin
  • Transcription
  • Histone-modifications

    Related Conference of Cancer Genomics and Epigenomics

    May 09-10, 2024

    4th Global Summit on Pharmaceutical Research

    Barcelona, Spain
    May 16-17, 2024

    18th World Drug Delivery Summit

    Rome, Italy
    May 30-31, 2024

    9th Pharmaceutical Chemistry Conference

    Paris, France
    July 25-26, 2024

    34th Annual European Pharma Congress

    Frankfurt, Germany
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2024

    3rd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2024

    3rd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 28-29, 2024

    12th International Conference on Clinical Trials

    Vancouver, Canada
    November 28-29, 2024

    39th World Congress on Pharmacology and Therapeutics

    Paris, France
    November 28-29, 2024

    4th International Conference on Pharmaceutical Chemistry

    Bali, Indonesia
    December 05-06, 2024

    17th World Drug Delivery Summit

    Dubai, UAE

    Cancer Genomics and Epigenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in